Showing results (121-130 of 217) with videos related to
Sort By:
Pageof 22
Annals of the Rheumatic Diseases|January 1, 1992
Different capabilities of monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis to induce glycosylation alterations of acute phase proteins in vitroA Mackiewicz, M Sobieska, M Kapciñska, et al.The Biochemical Journal|June 21, 2001
Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cellsM Kortylewski, P C Heinrich, M E Kauffmann, et al.Neuroscience Letters|April 18, 1998
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patientsP März, K Heese, C Hock, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 6, 1998
In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6M Peters, G Blinn, F Solem, et al.Cell Death & Disease|December 17, 2013
ADAM17 is a survival factor for microglial cells in vitro and in vivo after spinal cord injury in miceP M Vidal, E Lemmens, A Avila, et al.The American Journal of Pathology|November 14, 2000
Astrocytic alterations in interleukin-6/Soluble interleukin-6 receptor alpha double-transgenic miceA G Brunello, J Weissenberger, A Kappeler, et al.The Journal of Biological Chemistry|January 9, 1999
The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitroT Rakemann, M Niehof, S Kubicka, et al.European Journal of Biochemistry|July 1, 1994
Biosynthesis and half-life of the interleukin-6 receptor and its signal transducer gp130C Gerhartz, E Dittrich, T Stoyan, et al.Journal of Hepatology|October 6, 1997
TIMP expression in toxic and cholestatic liver injury in ratE Roeb, E Purucker, B Breuer, et al.FEBS Letters|October 29, 1990
The three carboxy-terminal amino acids of human interleukin-6 are essential for its biological activityA Krüttgen, S Rose-John, G Dufhues, et al.Pageof 22